The genetic or pharmacological blockade of GIPR attenuates obesity development in rodents [72,73], whereas GIP overexpression reduces diet-induced obesity and improves glucose metabolism [74]. This evidence concerns the gene GIP and obesity due to melanocortin 4 receptor deficiency.